SINGLE FOCUS OF ADENOCARCINOMA IN THE PROSTATE BIOPSY SPECIMEN IS NOTPREDICTIVE OF THE PATHOLOGICAL STAGE OF DISEASE

Citation
Rg. Bruce et al., SINGLE FOCUS OF ADENOCARCINOMA IN THE PROSTATE BIOPSY SPECIMEN IS NOTPREDICTIVE OF THE PATHOLOGICAL STAGE OF DISEASE, Urology, 48(1), 1996, pp. 75-79
Citations number
13
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
00904295
Volume
48
Issue
1
Year of publication
1996
Pages
75 - 79
Database
ISI
SICI code
0090-4295(1996)48:1<75:SFOAIT>2.0.ZU;2-1
Abstract
Objectives. To determine whether a very small focus of prostate cancer in a needle biopsy specimen correlates with organ-confined disease or with favorable disease parameters. Methods. Of 598 needle biopsies of the prostate performed from January 1990 through June 1994, 49 specim ens (8.2%) contained a microscopic focus (less than 2 mm in length of the entire biopsy core specimen) of adenocarcinoma, for these 49 patie nts, the clinical and pathologic features were correlated. Results. Of these 49 patients, 27 (55.1%) underwent either radical prostatectomy, with or without pelvic lymph node dissection (26), or pelvic lymph no de dissection alone (1). Seven of these 27 patients (25.9%) had extrap rostatic disease: lymph node involvement (1), positive surgical margin s (5), or seminal vesicle invasion (1). Ten of the 49 patients (20.4%) underwent radiotherapy, and 12 (24.5%) chose hormonal therapy. The pa thologic stage for these 22 patients could not be ascertained. However , despite the limited amount of disease in the biopsy specimen, 2 pati ents treated with radiotherapy suffered a relapse (mean interval to re currence, 11.5 months), and 3 patients treated with hormonal therapy ( early or delayed) had bony metastasis at the time of diagnosis. Overal l, 12 of the 49 patients (24.5%) had unfavorable disease (as defined b y extraprostatic disease on pathologic specimen, relapse after radioth erapy, or bony metastasis at the time of diagnosis). Conclusions. Thes e findings suggest that a microscopic focus of prostatic adenocarcinom a in a needle biopsy specimen, per se, does not predict the pathologic stage or the biologic behavior of a tumor.